MedPath

Tranexamic Acid to Prevent Operation in Chronic Subdural Hematoma

Conditions
Chronic subdural hematoma, chronisch subduraal hematoom, tranexamic acid, tranexaminezuur, burr-hole drainage, boorgatdrainage
Registration Number
NL-OMON29498
Lead Sponsor
Academic Medical Center Amsterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
140
Inclusion Criteria

· Age 50 years and above;

· On CT and/or MRI confirmed cSDH (isodense or hypodense subdural collection, uni- or bilateral);

Exclusion Criteria

· Primary surgical treatment based on one or more of the following symptoms or parameters: medically intractable headache, midline shift >10mm, imminent death within 24 hours;

· Structural causes for subdural haemorrhage, e.g. arachnoid cysts, cortical vascular malformations and a history of cranial surgery <1year;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Number of patients requiring surgery for cSDH within 12 weeks;<br /><br>2. Quality of life at 12 weeks, measured with the Short Form Health Survey (SF-36) questionnaire.<br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath